| HP与MVP方案治疗晚期非小细胞肺癌比较 |
| |
| 引用本文： | 周忠,高兴亚,林艳华.HP与MVP方案治疗晚期非小细胞肺癌比较[J].肿瘤学杂志,2004,10(1):23-24. |
| |
| 作者姓名： | 周忠 高兴亚 林艳华 |
| |
| 作者单位： | 贵州省贵阳市肺科医院,贵州,贵阳,550006 |
| |
| 摘 要： | 目的]比较HP及MVP方案对晚期非小细胞肺癌的疗效和毒性.方法]分析HP及MVP化疗方案治疗59例晚期非小细胞肺癌.结果]HP组有效率为50.0%(其中5例复治者中PR3例),MVP组有效率为51.6%,两组间无差异性(P＞0.05),毒性反应以骨髓抑制、恶心呕吐及腹泻为主.结论]HP方案是治疗晚期非小细胞肺癌的有效方案.
|
| 关 键 词： | 癌 非小细胞肺 药物疗法 羟基喜树碱 拓扑异构酶 顺铂 |
| 文章编号： | 1671-170X(2004)01-0023-02 |
| 修稿时间： | 2003年11月21 |
A Comparsion of HP Regimen and MVP Regimen for Advanced Non-small Cell Lung Cancer |
| |
| ZHOU Zhong,GAO Xing-ya,LIN Yan-hua.A Comparsion of HP Regimen and MVP Regimen for Advanced Non-small Cell Lung Cancer[J].Journal of Oncology,2004,10(1):23-24. |
| |
| Authors: | ZHOU Zhong GAO Xing-ya LIN Yan-hua |
| |
| Abstract: | To compare the efficacy and toxicity of HP regimen(HCPT and DDP)and MVP regimen(MMC,VDS and DDP)in advanced non-small cell lung cancer(NSCLC).The clinical data of59cases with advanced NSCLC treated with HP and MVP were analysed.The response rate was50%in patients with HP group(there were3PR in5previousely treated cases),51.6%in patients with MVP group.There was no significant difference between two groups(P>0.05).The major toxicities in the two groups were leucopenia,nausea and diarrhea.Conclusion]HP regimen is effective for the treatment of advanced NSCLC patients. |
| |
| Keywords: | cancer non-small cell lung drug therapy hydrosylcamptothecin topoisomerase cisplatin |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
